होमAthleticsRuti Aga and the Six-Year Lie: How a Forged Prescription Ended a Career
Athletics

Ruti Aga and the Six-Year Lie: How a Forged Prescription Ended a Career

**कोर उत्तर** रुती अगा पर एथलेटिक्स इंटेग्रिटी यूनिट (AIU) ने छह साल का प्रतिबंध लगाया है — दो साल मिथाइलप्रेडनिसोलोन की मौजूदगी के लिए, चार साल गवाही में हेर-फेर (टैंपरिंग) के लिए। मामला मार्च की चीन हाफ मैराथन में लिए गए नमूने से शुरू हुआ। प्रतिबंध 10 सितंबर से गिना गया। **मुख्य तथ्य** - रुती अगा, 32 वर्ष, इथियोपिया; 2019 टोक्यो मैराथन विजेता, वर्ल्ड मैराथन मेजर्स में तीन बार दूसरी। - छह साल का प्रतिबंध 10 सितंबर से प्रभावी — दो साल मौजूदगी, चार साल टैंपरिंग का जोड़। - मिथाइलप्रेडनिसोलोन WADA सूची का S9 ग्लूकोकोर्टिकॉइड है, कोई एनाबॉलिक स्टेरॉयड नहीं। - S9 पदार्थ केवल प्रतियोगिता के दौरान प्रतिबंधित हैं, वह भी इंजेक्शन, मुँह या रेक्टल मार्ग से। - पर्चा परिवार के एक गैर-पंजीकृत सदस्य ने बनाया; जिस क्लिनिक का नाम था वह अस्तित्व में नहीं था। **स्रोत** एथलेटिक्स इंटेग्रिटी यूनिट (AIU) का बयान, जैसा मूल रिपोर्ट में उद्धृत। नमूना मार्च 2024 की चीन हाफ मैराथन से; प्रतिबंध की शुरुआत 10 सितंबर। **संबंधित प्रश्नोत्तर** Q: छह साल का प्रतिबंध किन दो हिस्सों में बँटा है? A: दो साल मिथाइलप्रेडनिसोलोन की मौजूदगी के लिए और चार साल गवाही में हेर-फेर के लिए। Q: मिथाइलप्रेडनिसोलोन किस श्रेणी का पदार्थ है? A: यह WADA प्रतिबंधित सूची का S9 ग्लूकोकोर्टिकॉइड है, जो केवल प्रतियोगिता के दौरान प्रतिबंधित है — एनाबॉलिक स्टेरॉयड नहीं। Q: क्या 2019 टोक्यो मैराथन ख़िताब पर असर पड़ेगा? A: उल्लंघन उसके बाद की तारीख़ का है, इसलिए 2019 का ख़िताब अपने-आप रद्द नहीं माना जाता।

In March, at a half marathon in China, Ruti Aga crossed the finish line first. The result sheet recorded one name — and nothing else. No split time, no field depth, no mark to tell you what the race was worth. The scoreboard said she won. The scoreboard did not say that a sample collected at that same race would later erase the win and become the heaviest sanction of her career.

For years I have kept a ledger nobody asked for. Where most people log the winners, mine logs the missing names — the detail no results page ever prints. During the Hima Das summer I learned that the louder the headlines, the quieter the ledger. In Aga's case its largest missing name is not an athlete at all. It is a team physician — a doctor who may never have existed.

Aga is a 32-year-old Ethiopian marathoner. She won the 2026 Tokyo Marathon and finished second three times at the World Marathon Majors. By that measure she has been a 2:18-to-2:20 athlete — elite, but not of the generation that chases world records. The Athletics Integrity Unit (AIU) banned her for six years, counted from 10 September, the date she was provisionally suspended.

Now the number the headlines never carried: six years is the sum of two separate offences. Two years for the presence of methylprednisolone, and four years for tampering — for misleading evidence. In the AIU's sanction architecture that arithmetic is unambiguous, and it is the real story here.

Ruti Aga and the Six-Year Lie: How a Forged Prescription Ended a Career

First, the error every headline is repeating. Methylprednisolone is a glucocorticoid — class S9 on the WADA Prohibited List — not an anabolic steroid, which sits in class S1. The distinction is legally decisive. S9 glucocorticoids are prohibited only in-competition, and only by injection, oral or rectal route. A knee injection given out-of-competition is entirely lawful; it becomes a violation only if residues are present during competition.

At the Manchester results crew I learned that accuracy is not a lexicographer's fetish but a form of care. From a Portakabin I logged 1,142 women's field marks while nearly every televised cutaway went to the men's sprints. That night I decided a career must never be erased by an official's arithmetic. Calling this a "steroid" is not a slip of vocabulary; it places the whole case on the wrong plane, where Aga gets compared to athletes who took prohibited substances to go faster.

One fact is settled: methylprednisolone has no proven endurance benefit. It reduces inflammation. Intra-articular or peri-articular injection for knee synovitis is standard sports-medicine practice in distance runners. And that is exactly what makes this case so sharp — a real, documented treatment could have been defended with real records.

It also matters that China's half-marathon circuit has been a lucrative, low-risk income tier for East African marathoners — filling the gaps between Majors. But that same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same race.

The real question starts here, and it is about paper, not pharmacology. According to the AIU, Aga said the substance was given for a knee injury, and the prescription produced to support that was "written" by a member of her own family. That person was not a registered doctor. The clinic named on the prescription did not exist. Asked about it, the individual said he had used "an old prescription pad from a former workplace" — which the clinic flatly disowned.

That is not one lapse but three independent verification failures. This is where my six-week championship relocation comes back. When the 2026 Asian Athletics Championships were pulled from Ranchi and dropped into Bhubaneswar in six weeks, the real contest ran on the operational layer — who got a bed, a biomechanist, a lane at the Patiala camp. In athletics, fairness is decided in exactly that layer, and it is the layer most coverage skips. In Aga's case the layer was absent: no credentialed team physician, no therapeutic use exemption, no medical record that could stand up in a hearing.

Now the outcome. Two years for presence, four for tampering. The reason is plain: the genuine defence never reached the table, because a forged prescription was placed there instead.

And here is the counter-intuitive point nobody is making. In this case the heaviest damage was done not by the drug but by the athlete's own paperwork. Had the knee injection been documented, with the date and route accounted for, the very design of class S9 — in-competition only — would have opened a legitimate legal path. The forged prescription closed the one door that might have saved her. Of the six years, four belong not to the drug but to the story told about it.

One thing must stay straight, the way my ledger keeps reminding me: my sympathy for the 2026 generation never faded, but sympathy explains a failure, it does not remove a ban. And here there is no CAS-confirmed asterisk to weigh, because the case is unlikely to reach a court — the forgery finding rests on documents, and documents are almost impossible to overturn.

Ruti Aga and the Six-Year Lie: How a Forged Prescription Ended a Career

A six-year ban at 32 runs to 38. Ethiopian women's marathon depth is so great that even a 2:18 runner is not automatically selected. So the sanction is six years on paper and something like a career's end in practice. It will change nothing in Ethiopia's medal arithmetic — her three Major podiums were commercial-tier results, not championship conversions.

The most important lesson here is not the length of the ban. It is the direction enforcement is travelling — from detection toward document verification. The old question was what turned up in the sample; the new question is whether the paper is genuine. When I sat on the results crew writing names down, the lesson was the same in reverse — an empty lane does not always mean guilt. Twenty years on, that cuts the other way too: a forged prescription will not always mean dishonesty, but the sport will always read it that way — and there is no ledger that corrects that mistake.

संबंधित खिलाड़ी